Learn English: FDA Boosts Drug Approval Transparency (normal)

The FDA published a huge collection of letters detailing why some drugs were initially rejected.

These 'complete response letters' shed light on the often secretive drug approval process.

Although some information was already available, this centralized database significantly improves access.

This move towards transparency aims to increase public trust and understanding of drug development.